Trial for TDM-105795 update from research office

    Research/Science 10/11/2023
    The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.
    View this post in the Community →

    Similar Community Posts Join

    5 / 25 results

    Related Research

    6 / 17 results